How urologists are thinking about focal therapy for localized prostate cancer

A newly published study in Urologic Oncology has reported data from a survey carried out by researchers at the National Cancer Institute into “the current practice patterns and views among urologists regarding focal therapy for prostate cancer”. … READ MORE …

Detailed data on the use of proton beam radiation therapy centers

A presentation at the annual meeting of ASTRO in Boston last week has given us some detailed insight into exactly how many men in America with prostate cancer are getting treated each year with proton beam radiation therapy (PBRT). … READ MORE …

Evolution of the mCRPC treatment landscape

A new article by Jeffress in the cancer business publication OBR Green discusses the changing patterns of use of  the various approved drugs in the treatment of metastatic, castration-resistant prostate cancer (mCRPC). … READ MORE …

Cost and prevalence of PSA testing in Medicare patients > 70 years old

A recent article in Cancer has stimulated media coverage of the appropriate role of PSA testing in men of > 70 years of age and costs covered by Medicare for PSA tests in men over this age. … READ MORE …